-
[quick news] on February 28, 2019, the Ministry of Education: intensify the investigation and punishment of Postgraduates' Dissertations
Time of Update: 2019-02-28
Ministry of Education: Recently, the Ministry of Education issued a notice to strengthen the investigation and punishment of the falsification of Postgraduates' dissertations, which put forward a seri
-
Consistency evaluation to promote the overall competitiveness of pharmaceutical industry to be improved
Time of Update: 2019-02-27
[market analysis of chinapharma.com] a few days ago, Qingdao Baiyang pharmaceutical's metformin new drug Nida, which uses osmotic pump controlled release technology, was approved and listed by the FDA
-
How can R & D enterprises win the second half of the year
Time of Update: 2018-11-14
Recently, another wave of good news about the progress of new drugs came to China The NDA of the investigational drug adamumumab injection biological similar drug of Cinda biology was accepted by the
-
[exclusive] Q4 sprint: important products of famous enterprises such as Hengrui, Fosun, hausen, Huahai, dongyangguang and Xinda will be available
Time of Update: 2018-09-29
September is coming to an end Which blockbuster drugs are expected to be launched in the fourth quarter of 2018? Let's look at the following: competition for the first listing of new drugs Hengrui, Xi
-
Deloitte report: global life science development trend in 2018
Time of Update: 2018-03-19
Source: Sina medicine 2018-03-19 health life sciences refers to the application of biology and technology to promote health care, including pharmacy, medical technology, genomics, diagnostics, digital
-
Reveal the key role of key proteins in the development of systemic lupus erythematosus
Time of Update: 2017-12-06
Recently, in a research report published in the International Journal of experimental medicine, researchers from Northwestern University in the United States found that the macrophages in mice were Th
-
3rd Beijing California Chinese Biomedical entrepreneurs summit held
Time of Update: 2017-07-06
[forum of China Pharmaceutical network] on July 5, 2017, jointly sponsored by the Central Committee of the Democratic Party of agriculture and industry of China and the Management Committee of Beijing
-
Mr. Shi lichen: there are five models for the transformation of pharmaceutical enterprises to biopharmaceuticals
Time of Update: 2017-01-13
[expert opinion of China Pharmaceutical network] biopharmaceutical is a method of using living organisms to produce drugs It is an industry with large investment, long cycle and high R & D risk When c
-
Microchip biology: independent research and development of new anticancer drugs, creating many firsts
Time of Update: 2016-09-21
Recently, Lu Xianping, who used to fly all over the world, is even busier Just half an hour before Nanfang Daily's visit, he just finished filming a documentary about innovation on Mango and Korean TV
-
New rapid approval scheme for potential drugs in Europe
Time of Update: 2016-03-09
Source: on March 9, 2016, the European regulatory authorities launched a new plan to accelerate the approval of promising new drugs to address unmet medical needs, which will provide a lot of support
-
Pfizer run? Change company nationality or save $35 billion tax
Time of Update: 2016-03-02
Source: Biovalley 2016-03-02 March 2, 2016, if you want to evaluate the major events in 2015 in the biomedical industry So Pfizer's acquisition of Erjian must be among the top three Now, as the merger
-
The United States: patients in the new era of "precision medicine" can't afford high price drugs
Time of Update: 2015-06-16
Source: guangming.com June 16, 2015 according to the report of chinanet.com on June 14, scientists analyzed that drug development has opened the door for the new era of "accurate medicine", but at the
-
Hanyu pharmaceutical has completed technical review and on-site inspection of enkephalin
Time of Update: 2014-12-23
Previously, Yuan Jiancheng, President of Hanyu pharmaceutical, said at the shareholders' meeting that the company's heavyweight new drug enkephalin will follow the academic marketing route after it go
-
FDA awarded the breakthrough drug qualification of genetirizumab
Time of Update: 2014-12-19
Source: Ding Xiangyuan, Dec 19, 2014, US FDA awarded the qualification of rapunzumab, a gene trek VEGF inhibitor, as a breakthrough drug for diabetic retinopathy The drug has been granted priority rev
-
Gilead is charged with "inflated" price of hepatitis C drugs
Time of Update: 2014-12-12
Source: Ding Xiangyuan filed a class action lawsuit against the Philadelphia transportation authority on December 12, 2014, alleging that the price of heavy hepatitis C drug sovaldi of Gilead science
